Biofrontera (NASDAQ:BFRI) just reported results for the fourth quarter of 2023.
- Biofrontera reported earnings per share of $1.65. This was above the analyst estimate for EPS of -$1.19.
- The company reported revenue of $10.60 million.
- This was 8.03% worse than the analyst estimate for revenue of $11.52 million.